Biotie Therapies Oyj (Biotie Therapies Corporation) is a Finland-based biopharmaceutical company. It is a drug discovery and development company focused on the development of drugs for neurodegenerative and psychiatric disorders, such as Parkinson�s disease, Alzheimer�s disease and other cognitive disorders, alcohol and drug addictions and post traumatic stress disorder, as well as inflammatory and fibrotic liver disease.. It has a broad range of small molecule and biological drug candidates at different stages of clinical and pre-clinical development. The Company has alliances with global pharmaceutical companies such as Lundbeck and Roche. As of December 31, 2011, the Company operated four wholly owned subsidiaries, including Biotie Therapies International Oy, Biotie Therapies GmbH, based in Germany, Biotie Therapies Holding AG, based in Switzerland and Biotie Theriapies Inc, based in the United States.